UNIVERSITAS NEGERI SEMARANG
🇮🇩Indonesia
- Country
- 🇮🇩Indonesia
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.unnes.ac.id
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Garcinia Mangostana L Rind and Solanum Lycopersicum Fructus Trial to Prevent Exercise-induced Oxidative Stress
Phase 2
- Conditions
- Oxidative StressExertion; Excess
- Interventions
- Drug: Garcinia-mangostana-L-rind and Solanum-Lycopersicum-Fructus mixture-extractDrug: Placebo Control
- First Posted Date
- 2019-04-02
- Last Posted Date
- 2019-07-30
- Lead Sponsor
- Universitas Negeri Semarang
- Target Recruit Count
- 30
- Registration Number
- NCT03899454
- Locations
- 🇮🇩
Universitas Negeri Semarang, Semarang, Jawa Tengah, Indonesia
Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels
Completed
- Conditions
- Heart ArrestInflammatory ResponseOxidative StressSport Injury
- First Posted Date
- 2017-10-16
- Last Posted Date
- 2019-10-10
- Lead Sponsor
- Universitas Negeri Semarang
- Target Recruit Count
- 94
- Registration Number
- NCT03310450
- Locations
- 🇮🇩
Universitas Negeri Semarang, Semarang, Jawa Tengah, Indonesia
News
No news found